{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:01:04Z","timestamp":1792674064227,"version":"4.5.0"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Anemia and malignancy concurrently contribute to reduced quality of life, treatment intolerance, and increased morbidity and mortality, disproportionately affecting older adults, socioeconomically disadvantaged groups, and minority populations. Despite its clinical importance, national patterns and population-level disparities in the mortality burden associated with this comorbidity remain poorly characterized. This study aims to examine mortality trends associated with concurrent anemia and malignancy in the United States using CDC WONDER (Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research) database, with a focus on demographic and geographic disparities to inform targeted interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Mortality data from CDC WONDER were analyzed for individuals aged 65 years and older using ICD-10 codes C00\u2013C97 for malignancies and D50\u2013D64 for anemia. Age-adjusted mortality rates (AAMRs) and annual percent changes (APCs) were calculated by year, age, sex, race\/ethnicity, cancer type, and geographic region. Subgroup analyses focused on common anemia-associated cancers, including colorectal, gastric, lung, ovarian, female genital, breast, prostate, and hematologic malignancies, based on national prevalence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 1999 and 2020, there were 264,331 anemia and malignancy -related deaths among U.S. adults aged \u226565. The overall AAMR remained relatively stable moving from 31.5 in 1999 to 31.1 in 2020. A significant decline occurred through 2017 (APC: \u20130.86), followed by a sharp increase from 2017 to 2020 (APC: 4.63). Males had higher AAMRs than females (28.8 vs. 22.6). Black individuals had the highest mortality (42.4). The Midwest had the highest regional AAMR (30.6), while the South had the lowest (27.6). States in the top 90th percentile for AAMR included North Dakota, Maryland, Rhode Island, West Virginia, and DC. Nonmetropolitan areas had higher AAMRs than metropolitan ones (32.9 vs. 27.8). Colorectal cancer showed the largest decline (AAPC: -2.03) followed by gastric (AAPC: -1.96) and prostate cancer (AAPC: -1.40), while breast, lung, gynecological, and hematological cancers remained stable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among adults aged \u226565, anemia and malignancy-related mortality declined until 2017 but increased sharply through 2020, with highest rates in males, Black individuals, and nonmetropolitan\/Midwestern residents. Declines were seen in colorectal, gastric, and prostate cancers, while other cancers remained stable, highlighting the need for targeted interventions to reduce disparities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1722891","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:36:44Z","timestamp":1768973804000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Regional, demographic and temporal trends in anemia and malignant cancer-related mortality in U.S. older adults: a nationwide CDC WONDER analysis (1999\u20132020)"],"prefix":"10.3389","volume":"16","author":[{"given":"Muhammad Sarim Azad","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Medicine, Combined Military Hospital Lahore Medical College","place":["Lahore, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Chaudhary","sequence":"additional","affiliation":[{"name":"Department of Medicine, Fazaia Medical College","place":["Islamabad, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirha Imran","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Combined Military Hospital Institute of Medical Science","place":["Multan, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahiem Azeem","family":"Ajaz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rashid Latif Medical College","place":["Lahore, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arham","family":"Khalid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rawalpindi Medical University","place":["Rawalpindi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroosha","family":"Waheed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rawalpindi Medical University","place":["Rawalpindi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Hammad Jaber","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Alzaiem Alazhari University","place":["Khartoum, Sudan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","unstructured":"Cancer Stat Facts: Common Cancer Sites\n          \n          \n          Bethesda, MD\n          National Cancer Institute\n          \n          2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"E157","DOI":"10.5888\/pcd13.160211","article-title":"Heart disease and cancer deaths\u2014trends and projections in the United States, 1969\u20132020","volume":"13","author":"Weir","year":"2016","journal-title":"Prev Chronic Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00160-6","article-title":"Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"key":"B4","unstructured":"Anemia or iron deficiency\n          \n          \n          Atlanta, GA\n          FastStats\n          \n          2025"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2146\/ajhp060601","article-title":"Anemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocols","volume":"64","author":"Schwartz","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102837","article-title":"Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia","volume":"145","author":"Abdel-Razeq","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20809","article-title":"Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload","volume":"82","author":"Fung","year":"2007","journal-title":"Am J Hematol"},{"key":"B8","unstructured":"Transfusion iron overload\n          \n          \n            \n              Rasel\n              M\n            \n            \n              Hashmi\n              MF\n            \n            \n              Mahboobi\n              SK\n            \n          \n          Treasure Island, FL\n          StatPearls Publishing\n          StatPearls\n          \n          2024"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4082\/kjfm.17.0089","article-title":"Mild anemia and risk for all-cause, cardiovascular, and cancer deaths in apparently healthy elderly Koreans","volume":"40","author":"Han","year":"2019","journal-title":"Korean J Fam Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"794S","DOI":"10.1093\/jn\/132.4.794S","article-title":"Reversing productivity losses from iron deficiency: the economic case","volume":"132","author":"Hunt","year":"2002","journal-title":"J Nutr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq202","article-title":"Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use","volume":"21","author":"Schrijvers","year":"2010","journal-title":"Ann Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients","volume":"40","author":"Ludwig","year":"2004","journal-title":"Eur J Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004017","article-title":"How I treat cancer-associated anemia","volume":"136","author":"Gilreath","year":"2020","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S45236","article-title":"Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy","volume":"5","author":"Merlini","year":"2013","journal-title":"Cancer Manag Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0246202","DOI":"10.1371\/journal.pone.0246202","article-title":"Prevalence of anemia among Saudi patients with solid cancers at diagnosis in King Faisal Hospital, Taif Province, Kingdom of Saudi Arabia","volume":"16","author":"Almehmadi","year":"2021","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2217\/fon.11.24","article-title":"Management of anemia in cancer patients","volume":"7","author":"Calabrich","year":"2011","journal-title":"Future Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21812","article-title":"American Cancer Society\u2019s report on the status of cancer disparities in the United States, 2023","volume":"74","author":"Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2009.02.004","article-title":"Factors associated with anemia in patients with cancer admitted to an intensive care unit","volume":"25","author":"Cardenas-Turanzas","year":"2010","journal-title":"J Crit Care"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeu098","article-title":"Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients","volume":"113","author":"Baron","year":"2014","journal-title":"Br J Anaesth"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4308","article-title":"Impact of anemia on hospitalization and mortality in older adults","volume":"107","author":"Culleton","year":"2006","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/frhem.2025.1560766","article-title":"Trends in hemolytic anemia-related mortality in the United States from 1999-2022","volume":"4","author":"Tuin","year":"2025","journal-title":"Front Hematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40520-025-02982-0","article-title":"Iron deficiency anemia-related mortality trends in US older subjects, 1999 to 2019","volume":"37","author":"Zuin","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"B23","article-title":"Anemia is associated with poor outcomes of metastatic castration-resistant prostate cancer: a systematic review and meta-analysis","volume":"10","author":"Dai","year":"2018","journal-title":"Am J Transl Res"},{"key":"B24","unstructured":"Multiple Cause of Death Data on CDC WONDER"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E158","DOI":"10.5888\/pcd15.180151","article-title":"Transitions from heart disease to cancer as the leading cause of death in US states, 1999\u20132016","volume":"15","author":"Harding","year":"2019","journal-title":"Prev Chronic Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.01.032","article-title":"Rural-urban disparities: diabetes, hypertension, heart disease, and stroke mortality among black and white adults, 1999-2018","volume":"77","author":"Aggarwal","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B28","first-page":"1","article-title":"NCHS urban-rural classification scheme for counties. US department of health and human services","volume":"2","author":"Ingram","year":"2013","journal-title":"Cent Dis Control Prevent"},{"key":"B29","first-page":"1","article-title":"United States abridged life tables, 1996","volume":"47","author":"Anderson","year":"1998","journal-title":"Natl Vital Stat Rep"},{"key":"B30","unstructured":"Joinpoint Regression Program"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2019.03.001","article-title":"Impacts of aging on anemia tolerance, transfusion thresholds, and patient blood management","volume":"33","author":"Simon","year":"2019","journal-title":"Transfus Med Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1159\/000430137","article-title":"Enhanced suicidal erythrocyte death contributing to anemia in the elderly","volume":"36","author":"Lupescu","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02142","article-title":"Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO\/ASH clinical practice guideline update","volume":"37","author":"Bohlius","year":"2019","journal-title":"J Clin Oncol"},{"key":"B34","article-title":"ICD-10-CM Official Guidelines for Coding and Reporting Fiscal Year 2017 (October 1, 2016 \u2013 September 30, 2017)","year":"2016"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1089\/whr.2021.0092","article-title":"Impact of the transition from ICD-9-CM to ICD-10-CM on the rates of severe maternal morbidity in arkansas: an analysis of claims data","volume":"3","author":"Rezaeiahari","year":"2022","journal-title":"Womens Health Rep (New Rochelle)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00563","article-title":"Erythropoietin and cancer: the unintended consequences of anemia correction","volume":"5","author":"Debeljak","year":"2014","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0574","article-title":"Hematologic complications of immune checkpoint inhibitors","volume":"24","author":"Davis","year":"2019","journal-title":"Oncologist"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2023023","article-title":"Trends and all-cause mortality associated with multimorbidity of non-communicable diseases among adults in the United States, 1999-2018: a retrospective cohort study","volume":"45","author":"Sun","year":"2023","journal-title":"Epidemiol Health"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S90727","article-title":"Anemia in the frail, elderly patient. Clinical interventions in aging","volume":"11","author":"R\u00f6hrig","year":"2016","journal-title":"11"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3321-x","article-title":"Comorbidities, repeated hospitalizations, and age\u2009\u2265\u200980 years as indicators of anemia development in the older population","volume":"97","author":"Michalak","year":"2018","journal-title":"Ann Hematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071364","article-title":"Hyperferritinemia, low circulating iron and elevated hepcidin may negatively impact outcome in COVID-19 patients: a pilot study","volume":"11","author":"Szabo","year":"2022","journal-title":"Antioxidants"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2022.074","article-title":"Impact of COVID-19 on outcomes of patients with hematologic Malignancies: A multicenter, retrospective study","volume":"14","author":"Acar","year":"2022","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291178","article-title":"Risk factors for mortality among lung cancer patients with covid-19 infection: A systematic review and meta-analysis","volume":"18","author":"Wu","year":"2023","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00639","article-title":"Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review","volume":"7","author":"Riera","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"B45","unstructured":"Vital Statistics Reporting Guidance No. 03: Guidance for Certifying Deaths Due to Coronavirus Disease 2019 (COVID-19)\n          \n          \n          \n          2023"},{"key":"B46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40959-020-00086-4","article-title":"The prevalence of iron deficiency and anemia and their impact on survival in patients at a cardio-oncology clinic","volume":"6","author":"\u010ciburien\u0117","year":"2020","journal-title":"Cardiooncology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15338","article-title":"Greater anemia tolerance among hospitalized females compared to males","volume":"59","author":"Visagie","year":"2019","journal-title":"Transfusion"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-0036","article-title":"Sex differences in cancer incidence and survival: a pan-cancer analysis","volume":"29","author":"Dong","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13293-022-00469-5","article-title":"Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang","volume":"13","author":"Ma","year":"2022","journal-title":"Biol Sex Differ"},{"key":"B50","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/s12885-017-3516-x","article-title":"Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study","volume":"17","author":"Guiriguet","year":"2017","journal-title":"BMC Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12875-016-0440-0","article-title":"The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study","volume":"17","author":"Thompson","year":"2016","journal-title":"BMC Fam Pract"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.01.013","article-title":"The spectrum of sex differences in cancer","volume":"8","author":"Rubin","year":"2022","journal-title":"Trends Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3118","article-title":"Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia","volume":"103","author":"Sekeres","year":"2004","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-040218-043750","article-title":"Racism and health: evidence and needed research","volume":"40","author":"Williams","year":"2019","journal-title":"Annu Rev Public Health"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S1470-2045(21)00669-0","article-title":"Racial disparities in cancer care: can we close the gap","volume":"22","year":"2021","journal-title":"Lancet Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12916-024-03563-0","article-title":"Association between social determinants of health and survival among the US cancer survivors population","volume":"22","author":"Huang","year":"2024","journal-title":"BMC Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s40572-025-00507-5","article-title":"Hazardous environmental pollutants and cancer disparities: a systematic review on the consideration of race and ethnicity in environmental epidemiology research","volume":"12","author":"Schwalb","year":"2025","journal-title":"Curr Environ Health Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e2133205","DOI":"10.1001\/jamanetworkopen.2021.33205","article-title":"Racial and ethnic disparities among participants in precision oncology clinical studies","volume":"4","author":"Aldrighetti","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40615-016-0334-9","article-title":"Opportunities and challenges in precision medicine: improving cancer prevention and treatment for asian americans","volume":"5","author":"Trinh-Shevrin","year":"2018","journal-title":"J Racial Ethn Health Disparities"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e181235","DOI":"10.1001\/jamanetworkopen.2018.1235","article-title":"Geographic distribution and survival outcomes for rural patients with cancer treated in clinical trials","volume":"1","author":"Unger","year":"2018","journal-title":"JAMA Netw Open"},{"key":"B62","article-title":"Challenges of rural cancer care in the United States","volume":"29","author":"Charlton","year":"2015","journal-title":"Oncol (Williston Park)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-0092","article-title":"Making the case for investment in rural cancer control: an analysis of rural cancer incidence, mortality, and funding trends","volume":"26","author":"Blake","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6601a1","article-title":"Leading causes of death in nonmetropolitan and metropolitan areas\u2014United States, 1999\u20132014","volume":"66","author":"Moy","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-23-0152","article-title":"Cancer epidemiology in the Northeastern United States (2013\u20132017)","volume":"3","author":"Rees","year":"2023","journal-title":"Cancer Res Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-24-624","article-title":"Regional trends in colorectal cancer mortality in people aged 45\u201384 years in the US, 1999\u20132022","volume":"15","author":"Glisan","year":"2024","journal-title":"J Gastrointest Oncol"},{"key":"B67","unstructured":"History of ACS Recommendations for the Early Detection of Cancer in People Without Symptoms"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.23.2815","article-title":"Relation between medicare screening reimbursement and stage at diagnosis for older patients with colon cancer","volume":"296","author":"Gross","year":"2006","journal-title":"JAMA"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.7150\/jca.46661","article-title":"Colonoscopic screening is associated with reduced Colorectal Cancer incidence and mortality: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"J Cancer"},{"key":"B70","unstructured":"Data and progress\n          \n          \n          \n          2025"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e2118457","DOI":"10.1001\/jamanetworkopen.2021.18457","article-title":"Global incidence and mortality of gastric cancer, 1980\u20132018","volume":"4","author":"Wong","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgs038","article-title":"Temporal changes in the clinical approach to diagnosing prostate cancer","volume":"2012","author":"Hilton","year":"2012","journal-title":"J Natl Cancer Inst Monogr"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11869","article-title":"Association of the USPSTF grade D recommendation against prostate-specific antigen screening with prostate cancer\u2013specific mortality","volume":"5","author":"Burgess","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21863","article-title":"Breast cancer statistics, 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B76","unstructured":"Breast cancer mortality by clinical stage: low-risk cancers cause most breast cancer deaths each year\n          \n          2025"},{"key":"B77","unstructured":"HPV vaccines linked to drop in cervical cancer deaths\n          \n          \n            \n              Soucheray\n              S\n            \n          \n          Minneapolis, MN\n          CIDRAP\n          \n          2024"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3390\/cancers14081917","article-title":"Monoclonal antibodies in the treatment of diffuse large B-cell lymphoma: moving beyond rituximab","volume":"14","author":"Papageorgiou","year":"2022","journal-title":"Cancers"},{"key":"B79","article-title":"Tobacco use--United States, 1900-1999","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00255","article-title":"Trends in lung cancer incidence and mortality (1990-2019) in the United States: A comprehensive analysis of gender and state-level disparities","author":"Jani","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12099","article-title":"The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990\u20132017","volume":"40","author":"Liu","year":"2020","journal-title":"Cancer Commun"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1177\/0033354917736514","article-title":"Death certification errors and the effect on mortality statistics","volume":"132","author":"McGivern","year":"2017","journal-title":"Public Health Rep"},{"key":"B83","volume-title":"Strengthening forensic science in the United States: a path forward","year":"2009"},{"key":"B84","first-page":"1","article-title":"The validity of race and hispanic-origin reporting on death certificates in the United States: an update","author":"Arias","year":"2016","journal-title":"Vital Health Stat 2"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1722891\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:36:48Z","timestamp":1768973808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1722891\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":84,"alternative-id":["10.3389\/fonc.2026.1722891"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1722891","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1722891"}}